Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 903 entries
Sorted by: Best Match Show Resources per page
Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea.

The Journal of clinical and aesthetic dermatology

Del Rosso JQ.
PMID: 29515751
J Clin Aesthet Dermatol. 2017 Sep;10(9):39-42. Epub 2017 Sep 01.

Until recently, the potential modes of action of topical ivermectin in rosacea have been speculated but not studied. Short-term studies (12 week), long-term studies (up to 52 weeks), and case report series have now been completed, and topical ivermectin...

Cite
Del Rosso JQ. Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea. J Clin Aesthet Dermatol. 2017;10(9):39-42
Del Rosso, J. Q. (2017). Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea. The Journal of clinical and aesthetic dermatology, 10(9), 39-42.
Del Rosso, James Q. "Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea." The Journal of clinical and aesthetic dermatology vol. 10,9 (2017): 39-42.
Del Rosso JQ. Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea. J Clin Aesthet Dermatol. 2017 Sep;10(9):39-42. Epub 2017 Sep 01. PMID: 29515751; PMCID: PMC5749619.
Copy Download .nbib Format: NLM
New developments in the treatment of rosacea - role of once-daily ivermectin cream.

Clinical, cosmetic and investigational dermatology

Cardwell LA, Alinia H, Moradi Tuchayi S, Feldman SR.
PMID: 27051311
Clin Cosmet Investig Dermatol. 2016 Mar 18;9:71-7. doi: 10.2147/CCID.S98091. eCollection 2016.

Rosacea is a chronic dermatological disorder with a variety of clinical manifestations localized largely to the central face. The unclear etiology of rosacea fosters therapeutic difficulty; however, subtle clinical improvement with pharmacologic treatments of various drug categories suggests a...

Cite
Cardwell LA, Alinia H, Moradi Tuchayi S, et al. New developments in the treatment of rosacea - role of once-daily ivermectin cream. Clin Cosmet Investig Dermatol. 2016;9:71-7doi: 10.2147/CCID.S98091.
Cardwell, L. A., Alinia, H., Moradi Tuchayi, S., & Feldman, S. R. (2016). New developments in the treatment of rosacea - role of once-daily ivermectin cream. Clinical, cosmetic and investigational dermatology, 971-7. https://doi.org/10.2147/CCID.S98091
Cardwell, Leah A, et al. "New developments in the treatment of rosacea - role of once-daily ivermectin cream." Clinical, cosmetic and investigational dermatology vol. 9 (2016): 71-7. doi: https://doi.org/10.2147/CCID.S98091
Cardwell LA, Alinia H, Moradi Tuchayi S, Feldman SR. New developments in the treatment of rosacea - role of once-daily ivermectin cream. Clin Cosmet Investig Dermatol. 2016 Mar 18;9:71-7. doi: 10.2147/CCID.S98091. eCollection 2016. PMID: 27051311; PMCID: PMC4807898.
Copy Download .nbib Format: NLM
Field evaluation of the efficacy of common anthelmintics used in the control of gastrointestinal nematodes of sheep in Dabat district, Northwest Ethiopia.

Irish veterinary journal

Seyoum Z, Demessie Y, Bogale B, Melaku A.
PMID: 28596826
Ir Vet J. 2017 Jun 07;70:18. doi: 10.1186/s13620-017-0097-6. eCollection 2017.

BACKGROUND: Gastrointestinal nematode (GIN) infections are the main impediments that restrict the welfare and productivity of small ruminant in the world. Effective management of GINs in grazing sheep relies heavily on the use of highly efficacious anthelmintic drugs. However,...

Cite
Seyoum Z, Demessie Y, Bogale B, et al. Field evaluation of the efficacy of common anthelmintics used in the control of gastrointestinal nematodes of sheep in Dabat district, Northwest Ethiopia. Ir Vet J. 2017;70:18doi: 10.1186/s13620-017-0097-6.
Seyoum, Z., Demessie, Y., Bogale, B., & Melaku, A. (2017). Field evaluation of the efficacy of common anthelmintics used in the control of gastrointestinal nematodes of sheep in Dabat district, Northwest Ethiopia. Irish veterinary journal, 7018. https://doi.org/10.1186/s13620-017-0097-6
Seyoum, Zewdu, et al. "Field evaluation of the efficacy of common anthelmintics used in the control of gastrointestinal nematodes of sheep in Dabat district, Northwest Ethiopia." Irish veterinary journal vol. 70 (2017): 18. doi: https://doi.org/10.1186/s13620-017-0097-6
Seyoum Z, Demessie Y, Bogale B, Melaku A. Field evaluation of the efficacy of common anthelmintics used in the control of gastrointestinal nematodes of sheep in Dabat district, Northwest Ethiopia. Ir Vet J. 2017 Jun 07;70:18. doi: 10.1186/s13620-017-0097-6. eCollection 2017. PMID: 28596826; PMCID: PMC5461779.
Copy Download .nbib Format: NLM
Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin.

Frontiers in molecular neuroscience

Degani-Katzav N, Gortler R, Weissman M, Paas Y.
PMID: 28428744
Front Mol Neurosci. 2017 Apr 06;10:92. doi: 10.3389/fnmol.2017.00092. eCollection 2017.

The broad-spectrum anthelmintic drug ivermectin (IVM) activates and stabilizes an open-channel conformation of invertebrate chloride-selective glutamate receptors (GluClRs), thereby causing a continuous inflow of chloride ions and sustained membrane hyperpolarization. These effects suppress nervous impulses and vital physiological processes...

Cite
Degani-Katzav N, Gortler R, Weissman M, et al. Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin. Front Mol Neurosci. 2017;10:92doi: 10.3389/fnmol.2017.00092.
Degani-Katzav, N., Gortler, R., Weissman, M., & Paas, Y. (2017). Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin. Frontiers in molecular neuroscience, 1092. https://doi.org/10.3389/fnmol.2017.00092
Degani-Katzav, Nurit, et al. "Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin." Frontiers in molecular neuroscience vol. 10 (2017): 92. doi: https://doi.org/10.3389/fnmol.2017.00092
Degani-Katzav N, Gortler R, Weissman M, Paas Y. Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin. Front Mol Neurosci. 2017 Apr 06;10:92. doi: 10.3389/fnmol.2017.00092. eCollection 2017. PMID: 28428744; PMCID: PMC5382172.
Copy Download .nbib Format: NLM
First case of intestinal acariasis from Egypt.

SpringerPlus

Khalifa RM, Abdellatif MZ, Ahmed AK, Yones DA, El-Mazary AA, Aly LH, El-Seify MA, Haridi MA.
PMID: 26788440
Springerplus. 2016 Jan 12;5:28. doi: 10.1186/s40064-015-1584-4. eCollection 2016.

We are hereby reporting a case where the eggs and adults of the mold mites; Tyrophagus putrescentiae (Shrank) and the trophozoites of Blastocystis sp. were found in stool of three years old child from Minia City, Egypt. Intestinal mite...

Cite
Khalifa RM, Abdellatif MZ, Ahmed AK, et al. First case of intestinal acariasis from Egypt. Springerplus. 2016;5:28doi: 10.1186/s40064-015-1584-4.
Khalifa, R. M., Abdellatif, M. Z., Ahmed, A. K., Yones, D. A., El-Mazary, A. A., Aly, L. H., El-Seify, M. A., & Haridi, M. A. (2016). First case of intestinal acariasis from Egypt. SpringerPlus, 528. https://doi.org/10.1186/s40064-015-1584-4
Khalifa, Refaat M A, et al. "First case of intestinal acariasis from Egypt." SpringerPlus vol. 5 (2016): 28. doi: https://doi.org/10.1186/s40064-015-1584-4
Khalifa RM, Abdellatif MZ, Ahmed AK, Yones DA, El-Mazary AA, Aly LH, El-Seify MA, Haridi MA. First case of intestinal acariasis from Egypt. Springerplus. 2016 Jan 12;5:28. doi: 10.1186/s40064-015-1584-4. eCollection 2016. PMID: 26788440; PMCID: PMC4710620.
Copy Download .nbib Format: NLM
Comparative efficacy of pour-on eprinomectin and ivermectin against Sarcoptes scabiei in buffaloes.

Journal of parasitic diseases : official organ of the Indian Society for Parasitology

Nazir T, Katoch R, Yadav A, Godara R.
PMID: 27413304
J Parasit Dis. 2016 Jun;40(2):359-61. doi: 10.1007/s12639-014-0507-6. Epub 2014 Aug 24.

The efficacy of eprinomectin and ivermectin pour-on was evaluated against Sarcoptes scabiei in naturally infested buffaloes. Eighteen animals were allocated into three groups (A, B and C) of six animals each. Animals in group A were treated with eprinomectin...

Cite
Nazir T, Katoch R, Yadav A, et al. Comparative efficacy of pour-on eprinomectin and ivermectin against Sarcoptes scabiei in buffaloes. J Parasit Dis. 2014;40(2):359-61doi: 10.1007/s12639-014-0507-6.
Nazir, T., Katoch, R., Yadav, A., & Godara, R. (2016). Comparative efficacy of pour-on eprinomectin and ivermectin against Sarcoptes scabiei in buffaloes. Journal of parasitic diseases : official organ of the Indian Society for Parasitology, 40(2), 359-61. https://doi.org/10.1007/s12639-014-0507-6
Nazir, T, et al. "Comparative efficacy of pour-on eprinomectin and ivermectin against Sarcoptes scabiei in buffaloes." Journal of parasitic diseases : official organ of the Indian Society for Parasitology vol. 40,2 (2016): 359-61. doi: https://doi.org/10.1007/s12639-014-0507-6
Nazir T, Katoch R, Yadav A, Godara R. Comparative efficacy of pour-on eprinomectin and ivermectin against Sarcoptes scabiei in buffaloes. J Parasit Dis. 2016 Jun;40(2):359-61. doi: 10.1007/s12639-014-0507-6. Epub 2014 Aug 24. PMID: 27413304; PMCID: PMC4927489.
Copy Download .nbib Format: NLM
Scabies control with ivermectin.

Journal of paediatrics and child health

Isaacs D, Britton P.
PMID: 27329918
J Paediatr Child Health. 2016 May;52(5):579. doi: 10.1111/jpc.13219.

No abstract available.

Cite
Isaacs D, Britton P. Scabies control with ivermectin. J Paediatr Child Health. 2016;52(5):579doi: 10.1111/jpc.13219.
Isaacs, D., & Britton, P. (2016). Scabies control with ivermectin. Journal of paediatrics and child health, 52(5), 579. https://doi.org/10.1111/jpc.13219
Isaacs, David, and Britton, Philip. "Scabies control with ivermectin." Journal of paediatrics and child health vol. 52,5 (2016): 579. doi: https://doi.org/10.1111/jpc.13219
Isaacs D, Britton P. Scabies control with ivermectin. J Paediatr Child Health. 2016 May;52(5):579. doi: 10.1111/jpc.13219. PMID: 27329918.
Copy Download .nbib Format: NLM
Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of .

Parasite epidemiology and control

Turner HC, Truscott JE, Bettis AA, Hollingsworth TD, Brooker SJ, Anderson RM.
PMID: 27430028
Parasite Epidemiol Control. 2016 Jun;1(2):177-187. doi: 10.1016/j.parepi.2016.02.004.

INTRODUCTION: Soil-transmitted helminth (STH) infections are predominately controlled by providing children with preventive chemotherapy with either albendazole or mebendazole. However, neither has a high efficacy against METHODS: Using a STH transmission mathematical model, we evaluated the potential impact of...

Cite
Turner HC, Truscott JE, Bettis AA, et al. Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of . Parasite Epidemiol Control. 2016;1(2):177-187doi: 10.1016/j.parepi.2016.02.004.
Turner, H. C., Truscott, J. E., Bettis, A. A., Hollingsworth, T. D., Brooker, S. J., & Anderson, R. M. (2016). Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of . Parasite epidemiology and control, 1(2), 177-187. https://doi.org/10.1016/j.parepi.2016.02.004
Turner, Hugo C, et al. "Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of ." Parasite epidemiology and control vol. 1,2 (2016): 177-187. doi: https://doi.org/10.1016/j.parepi.2016.02.004
Turner HC, Truscott JE, Bettis AA, Hollingsworth TD, Brooker SJ, Anderson RM. Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of . Parasite Epidemiol Control. 2016 Jun;1(2):177-187. doi: 10.1016/j.parepi.2016.02.004. PMID: 27430028; PMCID: PMC4946157.
Copy Download .nbib Format: NLM
Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatmen.

European journal of microbiology & immunology

Shimogawara R, Hata N, Schuster A, Lesshafft H, Guedes de Oliveira S, Ignatius R, Akao N, Ohta N, Feldmeier H.
PMID: 24294495
Eur J Microbiol Immunol (Bp). 2013 Dec;3(4):258-66. doi: 10.1556/EuJMI.3.2013.4.4. Epub 2013 Nov 21.

Hookworm-related cutaneous larva migrans (Hr-CLM) is caused by animal hookworm larvae migrating in the human epidermis where they elicit an inflammatory response. This study describes the immunological profile in Hr-CLM patients. In 77 Hr-CLM patients from Manaus, Brazil, peripheral...

Cite
Shimogawara R, Hata N, Schuster A, et al. Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatmen. Eur J Microbiol Immunol (Bp). 2013;3(4):258-66doi: 10.1556/EuJMI.3.2013.4.4.
Shimogawara, R., Hata, N., Schuster, A., Lesshafft, H., Guedes de Oliveira, S., Ignatius, R., Akao, N., Ohta, N., & Feldmeier, H. (2013). Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatmen. European journal of microbiology & immunology, 3(4), 258-66. https://doi.org/10.1556/EuJMI.3.2013.4.4
Shimogawara, R, et al. "Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatmen." European journal of microbiology & immunology vol. 3,4 (2013): 258-66. doi: https://doi.org/10.1556/EuJMI.3.2013.4.4
Shimogawara R, Hata N, Schuster A, Lesshafft H, Guedes de Oliveira S, Ignatius R, Akao N, Ohta N, Feldmeier H. Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatmen. Eur J Microbiol Immunol (Bp). 2013 Dec;3(4):258-66. doi: 10.1556/EuJMI.3.2013.4.4. Epub 2013 Nov 21. PMID: 24294495; PMCID: PMC3838541.
Copy Download .nbib Format: NLM
Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes.

PloS one

Westergard T, Salari R, Martin JV, Brannigan G.
PMID: 26529248
PLoS One. 2015 Nov 03;10(11):e0142514. doi: 10.1371/journal.pone.0142514. eCollection 2015.

No abstract available.

Cite
Westergard T, Salari R, Martin JV, et al. Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes. PLoS One. 2015;10(11):e0142514doi: 10.1371/journal.pone.0142514.
Westergard, T., Salari, R., Martin, J. V., & Brannigan, G. (2015). Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes. PloS one, 10(11), e0142514. https://doi.org/10.1371/journal.pone.0142514
Westergard, Thomas, et al. "Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes." PloS one vol. 10,11 (2015): e0142514. doi: https://doi.org/10.1371/journal.pone.0142514
Westergard T, Salari R, Martin JV, Brannigan G. Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes. PLoS One. 2015 Nov 03;10(11):e0142514. doi: 10.1371/journal.pone.0142514. eCollection 2015. PMID: 26529248; PMCID: PMC4631515.
Copy Download .nbib Format: NLM
Update on the management of rosacea.

Clinical, cosmetic and investigational dermatology

Weinkle AP, Doktor V, Emer J.
PMID: 25897253
Clin Cosmet Investig Dermatol. 2015 Apr 07;8:159-77. doi: 10.2147/CCID.S58940. eCollection 2015.

Refining diagnostic criteria has identified key characteristics differentiating rosacea, a chronic skin disorder, from other common cutaneous inflammatory conditions. The current classification system developed by the National Rosacea Society Expert Committee consists of erythematotelangiectatic, papulopustular, phymatous, and ocular subtypes....

Cite
Weinkle AP, Doktor V, Emer J. Update on the management of rosacea. Clin Cosmet Investig Dermatol. 2015;8:159-77doi: 10.2147/CCID.S58940.
Weinkle, A. P., Doktor, V., & Emer, J. (2015). Update on the management of rosacea. Clinical, cosmetic and investigational dermatology, 8159-77. https://doi.org/10.2147/CCID.S58940
Weinkle, Allison P, et al. "Update on the management of rosacea." Clinical, cosmetic and investigational dermatology vol. 8 (2015): 159-77. doi: https://doi.org/10.2147/CCID.S58940
Weinkle AP, Doktor V, Emer J. Update on the management of rosacea. Clin Cosmet Investig Dermatol. 2015 Apr 07;8:159-77. doi: 10.2147/CCID.S58940. eCollection 2015. PMID: 25897253; PMCID: PMC4396587.
Copy Download .nbib Format: NLM
Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis.

Filaria journal

Makunde WH, Kamugisha LM, Massaga JJ, Makunde RW, Savael ZX, Akida J, Salum FM, Taylor MJ.
PMID: 14613509
Filaria J. 2003 Nov 06;2(1):15. doi: 10.1186/1475-2883-2-15.

BACKGROUND: In order to use a combination of ivermectin and albendazole for the elimination of lymphatic filariasis, it is important to assess the potential risk of increased adverse events in individuals infected with both lymphatic filariasis and onchocerciasis. We...

Cite
Makunde WH, Kamugisha LM, Massaga JJ, et al. Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis. Filaria J. 2003;2(1):15doi: 10.1186/1475-2883-2-15.
Makunde, W. H., Kamugisha, L. M., Massaga, J. J., Makunde, R. W., Savael, Z. X., Akida, J., Salum, F. M., & Taylor, M. J. (2003). Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis. Filaria journal, 2(1), 15. https://doi.org/10.1186/1475-2883-2-15
Makunde, William H, et al. "Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis." Filaria journal vol. 2,1 (2003): 15. doi: https://doi.org/10.1186/1475-2883-2-15
Makunde WH, Kamugisha LM, Massaga JJ, Makunde RW, Savael ZX, Akida J, Salum FM, Taylor MJ. Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis. Filaria J. 2003 Nov 06;2(1):15. doi: 10.1186/1475-2883-2-15. PMID: 14613509; PMCID: PMC293471.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 903 entries